A convenient assay for interferons based on reduction of cytopathic effect was developed. The number ofmanipulations and the lengths of the various incubation steps were reduced to a miniimum. The assay is simple to perform and can be completed within 16 h. Moreover, it can be used with various types of cells and a variety of viruses.
Interferon bioassays are based on measurement of a parameter associated with either virus production or cytopathic effect (CPE) on host cells (1, 3-6, 9, 11) . No single universally acceptable assay exists. In general, an assay is selected according to a given application. Thus, for example, monitoring of interferon activity during production and purification requires a rapid assay, and sensitivity can be sacrificed.
To meet the need for a rapid assay, we have developed a convenient microtiter assay based on reduction of CPE. The assay is quantitative, requires only 16 h, and can be adapted to many cell and virus combinations in common use. For simplicity, the number of technical manipulations was reduced to a minIimum. Various parameters affecting both speed and sensitivity were determined and are presented in this study. (2) . All viral dilutions used in the assay were made in MEM-10.
Interferons. Human leukocyte interferon was produced by inducing leukocyte buffy coats with Newcastle disease virus (8, 10 Fig. 1 .
RESULTS
Virus concentration. The effects of virus concentration on the bioassay were determined with VSV and several cell lines. It was found that the virus concentration affected both the sensitivity of the assay and the length of the incubation time required for 100% CPE in the virus control wells ( Table 1 ). The sensitivity of the assay could be increased by lowering the virus concentration. The total incubation time could be shortened to 16 h by increasing the amount of virus. A further increase in virus concentration lowered the sensitivity of the assay, but failed to shorten the total incubation time to less than 16 h.
Time of challenge. The effect of time of virus challenge after the addition of interferon on the sensitivity of the assay was determined. It was found that the protective effect of interferon increased gradually during the first 6 h of incubation with the cells (Table 2 ). This was observed both when the interferon and the cell suspension were added consecutively, as described above, and when interferon was added to an established monolayer. The sensitivity of the assay could be increased by a factor of 5-to 16-fold by varying the time of addition of the challenge virus. Sensitivity was consistently higher in assays with established monolayers. However, when a highly sensitive assay is not required, results can be obtained more rapidly and with fewer manipulations when the cell suspension is added directly to wells containing the interferon dilutions.
Cell concentration. Table 3 shows that both 3 ,000 PFU of VSV per well. A laboratory standard of leukocyte interferon of 640 U/ml was used. In assay 1, the interferon and the cell suspension were added to the wells consecutively as described in the text. In assay 2, interferon dilutions were added to established monolayers of the cells. Relative sensitivity is defined as the ratio of the observed titer to the actual titer of a standard interferon preparation. At 24 h, the MDBK cells were overgrown so that no 100% CPE could be observed at 24 h or even after 48 h. Quantitation of results may be affected by other factors, such as growth conditions before use or age of stock cells at the time of use. These factors are eliminated by comparison of titers of samples with standard interferon preparations. This rapid assay has proven to be a powerful tool for the purification of human leukocyte interferon (10) . The availability of the results of chromatographic steps by the next morning enabled chromatographic procedures to be performed on successive days, rather than days apart. In addition, the use of this interferon assay for determination of interferon titers in human serum is being evaluated.
